Lahouaria Hadri Selected Research

Sarcoplasmic Reticulum Calcium-Transporting ATPases

7/2013	Therapeutic efficacy of AAV1.SERCA2a in monocrotaline-induced pulmonary arterial hypertension.
7/2013	Benefit of SERCA2a gene transfer to vascular endothelial and smooth muscle cells: a new aspect in therapy of cardiovascular diseases.
1/2010	Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure.
3/2008	Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure.
9/2005	Sarco/endoplasmic reticulum Ca2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lahouaria Hadri Research Topics

Disease

7	Heart Failure 05/2019 - 03/2008
6	Pulmonary Hypertension 06/2020 - 01/2015
6	Vascular Remodeling 01/2020 - 07/2013
5	Hypertrophy 05/2019 - 08/2011
4	Pulmonary Arterial Hypertension 01/2022 - 07/2013
4	Hypoxia (Hypoxemia) 01/2020 - 01/2015
4	Cardiomegaly (Heart Hypertrophy) 05/2019 - 06/2010
4	Fibrosis (Cirrhosis) 01/2019 - 08/2011
3	Inflammation (Inflammations) 01/2021 - 08/2011
2	COVID-19 01/2021 - 01/2021
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 01/2020
1	Disease Progression 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020
1	Ventricular Tachycardia 01/2019
1	Hypertension (High Blood Pressure) 01/2018
1	Atherosclerosis 01/2016
1	Hyperaldosteronism (Conn Syndrome) 10/2014
1	Right Ventricular Hypertrophy 07/2013
1	Vascular System Injuries 07/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2013
1	Myocardial Infarction 03/2013
1	Cicatrix (Scar) 03/2013
1	Abdominal Aortic Aneurysm 09/2011
1	Body Weight (Weight, Body) 08/2011
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 06/2010
1	Heart Diseases (Heart Disease) 03/2009
1	Neointima 09/2005

Drug/Important Bio-Agent (IBA)

7	MonocrotalineIBA 01/2022 - 07/2013
5	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 07/2013 - 09/2005
3	CalciumIBA 10/2014 - 01/2010
2	Semaxinib (SU5416)IBA 01/2020 - 01/2018
2	CalcineurinIBA 05/2019 - 06/2010
2	Atrial Natriuretic Factor (ANF)IBA 05/2019 - 01/2015
2	CollagenIBA 01/2016 - 08/2011
2	salicylhydroxamic acid (SHAM)IBA 03/2013 - 06/2010
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	VaccinesIBA 01/2021
1	Vasodilator Agents (Vasodilators)IBA 06/2020
1	indium-bleomycinIBA 01/2020
1	Cyclic AMP (AMP, Cyclic)IBA 01/2020
1	Calcium-Transporting ATPases (Ca2+ ATPase)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	EnzymesIBA 01/2020
1	CatecholaminesIBA 05/2019
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 05/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2015
1	E 10 (E-10)IBA 01/2015
1	GalactosidasesIBA 07/2013
1	Protein Phosphatase 1IBA 03/2013
1	Green Fluorescent ProteinsIBA 09/2011
1	Pharmaceutical PreparationsIBA 08/2011
1	Stromal Interaction Molecule 1IBA 08/2011
1	ResistinIBA 08/2011
1	Messenger RNA (mRNA)IBA 08/2011
1	Connective Tissue Growth FactorIBA 08/2011
1	Fibronectins (Fibronectin)IBA 08/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2010
1	Small Interfering RNA (siRNA)IBA 03/2009
1	phospholambanIBA 03/2009

Therapy/Procedure

10	Therapeutics 08/2021 - 01/2010
1	Precision Medicine 01/2021
1	Ambulatory Care (Outpatient Care) 01/2021
1	Pneumonectomy (Lung Volume Reduction) 01/2019
1	Nebulizers and Vaporizers (Inhaler) 10/2018
1	RNAi Therapeutics 03/2009